Will glutathione treatments survive? Controversial BOP deadline looms.
For almost a year now, the California Board of Pharmacy (BOP) has been trying to…
Author | LymeDisease.org
Dorothy Leland is a longtime advocate and researcher focused on Lyme disease education, policy awareness, and patient support. She has contributed to numerous publications and works closely with medical professionals and organizations to improve understanding and treatment of tick-borne diseases.
For almost a year now, the California Board of Pharmacy (BOP) has been trying to…
This article was originally posted on Dr. Richard Horowitz’s Medical Detective Substack. It is Part…
By Fred Diamond For those navigating the complexities of chronic Lyme disease, Dr. Bill Rawls…
There were few books about Lyme disease when author Danial Ardrey wrote DEAD END HOST…
The Australian Senate has launched an inquiry into the access to diagnosis and treatment for…
By Lowell Miller I became a host for Borrelia burgdorferi (the microbe at the root…
By Steve Ehrlich Like many people reading this, I have chronic Lyme disease. My battle…
By Fred Diamond Lyme disease has long been one of the most misunderstood and underfunded…
By Jennifer Meisenbacher-Molzen In 2006, on the Fourth of July, my friend Kelly handed me…
On January 8, the California Board of Pharmacy (BOP) was discussing potential restrictions on Category…
End of content
End of content